Wednesday, July 8, 2026

pharma · Hypertriglyceridemia · Asthma · GRCE

Grace Therapeutics

Grace Therapeutics clinical programs — 29 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

3009, boul. de la Concorde E., Suite 102, Laval, Québec H7E 2B5, CA HQ
18 Employees
Public company Type
GRCE · NYSE Ticker
Company details
Status
Public
HQ
3009, boul. de la Concorde E., Suite 102, Laval, Québec H7E 2B5, CA
Employees
18
Programs
29
Drugs
37
Patents
34
Intelligence · Clinical Programs

Grace Therapeutics projects

29 ClinicalTrials.gov programs sponsored by Grace Therapeutics.

Grace Therapeutics has 29 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CaPre

    Grace Therapeutics

    Hypertriglyceridemia

    phase 3 small molecule completed

    2 trials
  2. FF/UMEC/VI

    Grace Therapeutics

    Asthma

    phase 3 small molecule active

    1 trial
  3. GS-100

    Grace Therapeutics

    NGLY1 Deficiency

    phase 3 gene therapy active

    1 trial
  4. GTX-104

    Grace Therapeutics

    Aneurysmal Subarachnoid Hemorrhage (aSAH)

    phase 3 small molecule active

    1 trial
  5. Imiquimod 5% cream

    Grace Therapeutics

    Superficial Basal Cell Carcinoma

    phase 3 small molecule completed

    1 trial
  6. QVM149

    Grace Therapeutics

    Asthma

    phase 3 small molecule terminated

    1 trial
  7. CaPre (TM)

    Grace Therapeutics

    Hypertriglyceridemia

    phase 2 small molecule completed

    1 trial
  8. Clonidine

    Grace Therapeutics

    Pregnancy Related

    phase 2 small molecule completed

    1 trial
  9. Eat Well Live Well Nutrition Program

    Grace Therapeutics

    Diabetes or Diabetes Prevention

    phase 2 other completed

    1 trial
  10. Ketamine

    Grace Therapeutics

    Obstetric Pain

    phase 2 small molecule completed

    1 trial
  11. Lipid Lowering Medication

    Grace Therapeutics

    Hypertriglyceridemia

    phase 2 small molecule completed

    1 trial
  12. GTX-101

    Grace Therapeutics

    Postherpetic Neuralgia

    phase 1 small molecule active

    1 trial
  13. GTX-102 medium dose fast Period 1 and Period 2

    Grace Therapeutics

    Ataxia Telangiectasia

    phase 1 small molecule active

    1 trial
  14. GTX-104

    Grace Therapeutics

    Aneurysmal Subarachnoid Hemorrhage

    phase 1 small molecule completed

    1 trial
  15. Hydromorphone

    Grace Therapeutics

    Pain

    phase 1 small molecule completed

    1 trial
  16. Ketamine (Ketalar)

    Grace Therapeutics

    Pain

    phase 1 small molecule active

    1 trial
  17. Ketamine (Ketalar) Dose Level 1

    Grace Therapeutics

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial
  18. Desvenlafaxine Succinate

    Grace Therapeutics

    Vascular Depression

    approved small molecule active

    1 trial
  19. Tirzepatide

    Grace Therapeutics

    Prader-Willi Syndrome

    approved small molecule active

    1 trial
  20. Apolipoprotein (ApoE) detection

    Grace Therapeutics

    Senile Plaques

    gene therapy active

    1 trial
  21. Benralizumab

    Grace Therapeutics

    Asthma; Eosinophilic

    small molecule active

    1 trial
  22. Bupivacaine / fentaNYL

    Grace Therapeutics

    Depression, Postpartum

    small molecule completed

    1 trial
  23. ClearSight HPI Monitoring system

    Grace Therapeutics

    Anesthesia, Epidural

    other completed

    1 trial
  24. Control (Standard treatment)

    Grace Therapeutics

    Moisture Associated Skin Damage

    small molecule active

    1 trial
  25. Fospropofol (Lusedra®) 6.5

    Grace Therapeutics

    Interstitial Cystitis

    small molecule terminated

    1 trial
  26. Lung Ultrasound (LUS)

    Grace Therapeutics

    Community-acquired Pneumonia

    other active

    1 trial
  27. Rapid test for diagnosis orientation

    Grace Therapeutics

    Flu

    other active

    1 trial
  28. Zinc gluconate

    Grace Therapeutics

    HIV

    other completed

    1 trial
  29. progastrin

    Grace Therapeutics

    Colon Cancer Screening

    other terminated

    1 trial

Frequently asked questions

How many clinical projects does Grace Therapeutics have?

29 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.